Growth Metrics

Viemed Healthcare (VMD) Other financing activities (2024 - 2025)

Viemed Healthcare posted quarterly Other financing activities of $115000.0 for Q4 2025, up 447.62% year-on-year from $21000.0 in Q4 2024, and up 447.62% on a QoQ basis from $21000.0 in Q4 2024.

Viemed Healthcare (VMD) has 2 years of Other financing activities data on file, last reported at $115000.0 in Q4 2025.

  • For the quarter ending Q4 2025, Other financing activities rose 447.62% year-over-year to $115000.0; the trailing twelve-month figure through Dec 2025 stood at $156000.0 (up 280.49% YoY), and the FY2025 full-year result was $115000.0, down 40.1% from the prior year.
  • Other financing activities for Q4 2025 stood at $115000.0, up from $21000.0 in the prior quarter.
  • Across five years, Other financing activities topped out at $115000.0 in Q4 2025 and bottomed at $20000.0 in Q3 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Viemed Healthcare 373.53 Mn 365.70 Mn 42.83 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 115,000.00
Dec 31, 2025 115,000.00
Dec 31, 2024 21,000.00
Dec 31, 2024 21,000.00
Sep 30, 2024 20,000.00
Sep 30, 2024 20,000.00